Overview

Treatment of Binge Eating in Obese Patients in Primary Care

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
0
Participant gender:
All
Summary
This study will test the effectiveness of two empirically-supported but distinct treatments for recurrent binge eating in obese patients: 1) Cognitive Behavior Therapy, using a pure self-help approach and 2) sibutramine, an anti-obesity medication also found to have efficacy for binge eating. Self-help Cognitive Behavior Therapy and sibutramine will be administered alone and in combination in a primary care setting.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Yale University
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)
Treatments:
Sibutramine
Criteria
Inclusion Criteria:

- Obese (BMI >= 30)

Exclusion Criteria:

- Medication regimen that represents medical contraindication to sibutramine

- Serious unstable or uncontrolled medical conditions that represent contraindication to
sibutramine

- Pregnancy